Why do omega 3s lower triglycerides

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Omega-3 fatty acids lower triglycerides primarily by reducing the liver's production of very-low-density lipoprotein (VLDL) particles, which carry triglycerides in the bloodstream. Studies show that high-dose omega-3 supplementation (2-4 grams daily) can reduce triglyceride levels by 20-50% in individuals with hypertriglyceridemia. The American Heart Association recommends 2-4 grams of EPA and DHA daily under medical supervision for patients with high triglycerides. These effects are most pronounced with prescription omega-3 formulations like icosapent ethyl, which reduced cardiovascular events by 25% in the REDUCE-IT trial (2018).

Key Facts

Omega-3s reduce triglyceride production in the liver by 20-50% at therapeutic doses (2-4 grams daily)
Prescription omega-3 medication icosapent ethyl reduced cardiovascular events by 25% in the REDUCE-IT trial (2018)
The American Heart Association recommends 2-4 grams of EPA and DHA daily for patients with high triglycerides
Omega-3s increase the clearance of triglyceride-rich lipoproteins from the bloodstream
High triglyceride levels (>150 mg/dL) affect approximately 25% of U.S. adults

Overview

Omega-3 fatty acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) from fish oil, have been studied since the 1970s for their cardiovascular benefits. The Greenland Inuit studies in the 1970s first observed low cardiovascular disease rates despite high-fat diets rich in marine omega-3s. Triglycerides are a type of fat in the blood that, when elevated (>150 mg/dL), increase cardiovascular risk. Approximately 25% of U.S. adults have elevated triglycerides. The FDA approved the first prescription omega-3 medication (Lovaza) in 2004 specifically for treating very high triglycerides (>500 mg/dL). Subsequent research led to more purified formulations like Vascepa (icosapent ethyl), approved in 2012. The global omega-3 supplement market reached $4.1 billion in 2020, reflecting widespread use for cardiovascular health.

How It Works

Omega-3 fatty acids lower triglycerides through multiple mechanisms. First, they reduce hepatic production of very-low-density lipoprotein (VLDL) particles, the primary carriers of triglycerides in the bloodstream. EPA and DHA inhibit diacylglycerol acyltransferase, a key enzyme in triglyceride synthesis. Second, omega-3s enhance the clearance of triglyceride-rich lipoproteins by increasing lipoprotein lipase activity, which breaks down triglycerides for energy storage or use. Third, they promote fatty acid oxidation in the liver, reducing substrate availability for triglyceride production. Fourth, omega-3s may decrease the production of apolipoprotein B-100, a structural protein in VLDL particles. These combined effects typically reduce triglyceride levels by 20-50% at therapeutic doses of 2-4 grams daily, with greater reductions in individuals with higher baseline levels.

Why It Matters

Lowering triglycerides with omega-3s has significant clinical importance because elevated triglycerides independently increase cardiovascular risk. The REDUCE-IT trial (2018) demonstrated that icosapent ethyl reduced cardiovascular events by 25% in high-risk patients, leading to updated treatment guidelines. Beyond cardiovascular benefits, omega-3s may reduce inflammation, improve endothelial function, and stabilize atherosclerotic plaques. For patients with severe hypertriglyceridemia (>500 mg/dL), omega-3s can prevent pancreatitis, a potentially life-threatening complication. The American Heart Association recommends omega-3 supplementation alongside lifestyle changes for triglyceride management, representing a non-statin approach to lipid control that benefits millions worldwide.